FilingReader Intelligence

Maccura Biotechnology approves governance updates, elects new director

October 16, 2025 at 05:15 AM UTCBy FilingReader AI

Maccura Biotechnology held its third extraordinary general meeting of shareholders on October 15, 2025, approving several key proposals. Shareholders voted to adjust the organizational structure and revise the company's articles of association. Concurrently, various corporate governance policies were updated, including revisions to the rules of procedure for shareholder meetings, board of directors, independent directors, related-party transactions, and external investment management.

Additionally, shareholders approved a proposal for the company to provide guarantees for its distributors applying for bank credit lines. This measure aims to support the company’s business relationships and operational stability.

The meeting also addressed board changes, with Ms. Yin Shan resigning as a non-independent director due to organizational restructuring, though she will continue as the company's financial head. Following this, Mr. You Ping was elected as the new employee representative director, effective from October 15, 2025, bringing his expertise as a certified public accountant and tax agent to the board.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:300463Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Maccura Biotechnology publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →